USSTOCK.TODAY
Market Closed
Log in Sign up

Bio-Rad shares rise ahead of Q3 earnings release

Earnings Whispers · ·by G4L

BIO
BIO Bio-Rad Laboratories Inc
$388.31 +1.77%
View chart & analysis →
  1. 1Bio-Rad shares have risen 9.5% since the recent update.
  2. 2The consensus revenue for Bio-Rad in Q3 is approximately $661.9 million.
  3. 3The consensus earnings per share (EPS) for Bio-Rad in Q3 is $2.61.

So what's the key point?

Bio-Rad shares have recently risen by about 9.5%. Expectations are growing ahead of the upcoming Q3 earnings release predicted by experts.

Source Earnings Whispers · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →